Showing results (351-360 of 422) with videos related to

Sort By:
Pageof 43
Journal of Clinical Psychopharmacology|January 16, 2010
Desvenlafaxine for the prevention of relapse in major depressive disorder: results of a randomized trialKarl Rickels, Stuart A Montgomery, Karen A Tourian, et al.
Clinical Pharmacology and Therapeutics|January 18, 2024
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic ProteinsYow-Ming C Wang, Ping Ji, Sudharshan Hariharan, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 26, 2018
FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive ShockFortunato Senatore, Gowraganahalli Jagadeesh, Martin Rose, et al.
Science Robotics|November 13, 2024
NeuralFeels with neural fields: Visuotactile perception for in-hand manipulationSudharshan Suresh, Haozhi Qi, Tingfan Wu, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 2, 2019
Correction to: FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive ShockFortunato Senatore, Gowraganahalli Jagadeesh, Martin Rose, et al.
American Journal of Epidemiology|July 11, 2023
Socioeconomic Inequalities and Molecular Risk for Aging in Young AdulthoodCecilia Potente, Justin Chumbley, Wenjia Xu, et al.
Cell Research|August 28, 2013
Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator systemAlbert W Cheng, Haoyi Wang, Hui Yang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 17, 2022
Socioeconomic inequalities in molecular risk for chronic diseases observed in young adulthoodMichael J Shanahan, Steven W Cole, Sudharshan Ravi, et al.
The British Journal of Ophthalmology|October 4, 2020
Impact of COVID-19 pandemic on uveitis patients receiving immunomodulatory and biological therapies (COPE STUDY)Aniruddha Kishandutt Agarwal, Sridharan Sudharshan, Padmamalini Mahendradas, et al.
The Journal of Biological Chemistry|April 2, 2011
A novel mode of protein kinase inhibition exploiting hydrophobic motifs of autoinhibited kinases: discovery of ATP-independent inhibitors of fibroblast growth factor receptorSudharshan Eathiraj, Rocio Palma, Marscha Hirschi, et al.
Pageof 43